Literature DB >> 24713648

BNP-guided therapy for chronic heart failure: anything more than just an attractive concept?

Martin R Cowie1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24713648     DOI： 10.1093/eurheartj/ehu134

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  4 in total

1.  Biomarker Guided Therapy in Chronic Heart Failure.

Authors:  Hans-Peter Brunner-La Rocca; Sema Bektas
Journal:  Card Fail Rev       Date:  2015-10

2.  A Novel Liposomal S-Propargyl-Cysteine: A Sustained Release of Hydrogen Sulfide Reducing Myocardial Fibrosis via TGF-β1/Smad Pathway.

Authors:  Yicheng Mao; Yi Zhun Zhu; Ba Hieu Tran; Ying Yu; Lingling Chang; Bo Tan; Wanwan Jia; Ying Xiong; Tao Dai; Rui Zhong; Weiping Zhang; Van Minh Le; Peter Rose; Zhijun Wang
Journal:  Int J Nanomedicine       Date:  2019-12-24

3.  Admission NT-ProBNP in Myocardial Infarction: an Alert Sign?

Authors:  Luís Beck da Silva
Journal:  Arq Bras Cardiol       Date:  2019-12       Impact factor: 2.000

4.  Increased B-type-natriuretic peptide promotes myocardial cell apoptosis via the B-type-natriuretic peptide/long non-coding RNA LSINCT5/caspase-1/interleukin 1β signaling pathway.

Authors:  Xian Zhang; Minglei Sha; Yuting Yao; Jia Da; Dadao Jing
Journal:  Mol Med Rep       Date:  2015-08-25       Impact factor: 2.952
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.